Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00AVR
|
||||
| Former ID |
DNC011051
|
||||
| Drug Name |
APLYSINOPSIN
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551219] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C14H14N4O
|
||||
| Canonical SMILES |
CN1C(=CC2=CNC3=CC=CC=C32)C(=O)N(C1=N)C
|
||||
| InChI |
1S/C14H14N4O/c1-17-12(13(19)18(2)14(17)15)7-9-8-16-11-6-4-3-5-10(9)11/h3-8,15-16H,1-2H3/b12-7+,15-14?
|
||||
| InChIKey |
AZGOVLGMSGAOMP-FZYUQVBKSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [551219] | |
| 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [551219] | ||
| WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
| Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| SIDS Susceptibility Pathways | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.